139 related articles for article (PubMed ID: 23332108)
41. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
[TBL] [Abstract][Full Text] [Related]
42. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of thrombin inactivation by immobilized heparin.
Byun Y; Jacobs HA; Kim SW
J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
[TBL] [Abstract][Full Text] [Related]
44. Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: different mechanisms for heparin and sulfated galactans.
Melo FR; Pereira MS; Foguel D; Mourão PA
J Biol Chem; 2004 May; 279(20):20824-35. PubMed ID: 14996843
[TBL] [Abstract][Full Text] [Related]
45. The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.
Mitroulis I; Kambas K; Anyfanti P; Doumas M; Ritis K
Expert Opin Ther Targets; 2011 Jan; 15(1):75-89. PubMed ID: 21062231
[TBL] [Abstract][Full Text] [Related]
46. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
[TBL] [Abstract][Full Text] [Related]
47. Significance of thrombin-receptors of thrombocytes for the interaction of heparins and low-molecular-weight heparin in human whole blood clotting.
Harenberg J; Schuler M; Zimmermann R; Heptner W
Haemostasis; 1988; 18 Suppl 3():20-2. PubMed ID: 2840370
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.
Ndonwi M; Burlingame OO; Miller AS; Tollefsen DM; Broze GJ; Goldberg DE
Blood; 2011 Jun; 117(23):6347-54. PubMed ID: 21511958
[TBL] [Abstract][Full Text] [Related]
49. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex.
Sheehan JP; Lan HC
Blood; 1998 Sep; 92(5):1617-25. PubMed ID: 9716589
[TBL] [Abstract][Full Text] [Related]
50. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
Chan AK; Berry LR; Monagle PT; Andrew M
Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
[TBL] [Abstract][Full Text] [Related]
51. Low molecular weight heparin improves peritoneal ultrafiltration and blocks complement and coagulation.
Bazargani F; Albrektsson A; Yahyapour N; Braide M
Perit Dial Int; 2005; 25(4):394-404. PubMed ID: 16022098
[TBL] [Abstract][Full Text] [Related]
52. [Comparative analysis of unfractionated and low molecular weight heparins on the polymerization process of fibrin].
Barkagan ZS; Solomina TA
Biull Eksp Biol Med; 1997 Sep; 124(9):346-7. PubMed ID: 9445624
[No Abstract] [Full Text] [Related]
53. The effect of different anticoagulants on thrombin generation.
Petros S; Siegemund T; Siegemund A; Engelmann L
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):131-7. PubMed ID: 16479195
[TBL] [Abstract][Full Text] [Related]
54. Heparin-stimulated inhibition of factor IXa generation and factor IXa neutralization in plasma.
Pieters J; Lindhout T; Willems G
Blood; 1990 Aug; 76(3):549-54. PubMed ID: 2165828
[TBL] [Abstract][Full Text] [Related]
55. Advantages of low molecular weight heparin over standard heparin: facts and fiction.
Vinazzer H
Semin Thromb Hemost; 1991 Oct; 17(4):385-8. PubMed ID: 1666459
[No Abstract] [Full Text] [Related]
56. The ultrasound frequency determines the degree of intrinsic coagulation activation.
Stief TW; Klingmüller V
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):440-4. PubMed ID: 22610138
[TBL] [Abstract][Full Text] [Related]
57. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
Wun TC
Blood; 1992 Jan; 79(2):430-8. PubMed ID: 1346095
[TBL] [Abstract][Full Text] [Related]
58. Ways to bypass a blocked tenase complex.
Tuddenham EG
Thromb Haemost; 2006 Jan; 95(1):1-2. PubMed ID: 16543953
[No Abstract] [Full Text] [Related]
59. The significance of circulating factor IXa in blood.
Butenas S; Orfeo T; Gissel MT; Brummel KE; Mann KG
J Biol Chem; 2004 May; 279(22):22875-82. PubMed ID: 15039440
[TBL] [Abstract][Full Text] [Related]
60. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
